NovoCure Limited

NasdaqGS:NVCR Stock Report

Market Cap: US$1.9b

NovoCure Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:NVCR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 May 25SellUS$10,604Mukund ParavasthuIndividual592US$17.91
03 Mar 25SellUS$4,634Mukund ParavasthuIndividual250US$18.54
03 Mar 25SellUS$38,055Ashley CordovaIndividual2,053US$18.54
03 Mar 25SellUS$5,071Uri WeinbergIndividual268US$18.92
03 Mar 25SellUS$46,841Frank LeonardIndividual2,527US$18.54
28 Feb 25SellUS$39,688Mukund ParavasthuIndividual2,014US$20.55
28 Feb 25SellUS$266,126Ashley CordovaIndividual13,494US$20.55
28 Feb 25SellUS$86,949Uri WeinbergIndividual4,637US$18.78
28 Feb 25SellUS$296,257Frank LeonardIndividual15,036US$20.55
27 Feb 25SellUS$19,844Nicolas LeupinIndividual991US$20.55
27 Feb 25SellUS$27,773Michael PuriIndividual1,387US$20.55
11 Jan 25SellUS$57,906Mukund ParavasthuIndividual2,160US$26.81
02 Nov 24SellUS$734Mukund ParavasthuIndividual44US$16.69
01 Nov 24SellUS$9,531Frank LeonardIndividual598US$15.94
01 Nov 24SellUS$2,540Mukund ParavasthuIndividual160US$15.88
31 Oct 24SellUS$12,792Michael PuriIndividual810US$15.79
02 Aug 24SellUS$13,857Ashley CordovaIndividual688US$20.14
04 Jun 24SellUS$23,027Timothy ScannellIndividual964US$23.89
04 Jun 24SellUS$23,025Kinyip LeungIndividual964US$23.89
04 Jun 24SellUS$23,033William VernonIndividual964US$23.89

Insider Trading Volume

Insider Buying: NVCR insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of NVCR?
Owner TypeNumber of SharesOwnership Percentage
General Public5,574,0885%
Individual Insiders10,743,2809.64%
Institutions95,168,26685.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 82.11% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.6%
FMR LLC
16,229,751US$270.2m-0.01%0.02%
12.3%
Capital Research and Management Company
13,723,636US$228.5m11.9%0.01%
11.6%
BlackRock, Inc.
12,946,995US$215.6m0.01%no data
10.6%
The Vanguard Group, Inc.
11,796,109US$196.4m-0.41%no data
8.04%
Hansjoerg Wyss
8,967,046US$149.3m10.1%no data
4.95%
Soleus Capital Management, L.P.
5,521,414US$91.9m102%6.48%
3.03%
T. Rowe Price Group, Inc.
3,374,259US$56.2m-34.2%0.01%
2.37%
State Street Global Advisors, Inc.
2,641,445US$44.0m-3.24%no data
2.15%
Geode Capital Management, LLC
2,400,182US$40.0m-0.21%no data
1.15%
Northern Trust Global Investments
1,284,350US$21.4m39.1%no data
1.1%
UBS Asset Management AG
1,225,754US$20.4m15.3%no data
1.04%
Baillie Gifford & Co.
1,161,310US$19.3m-30%0.01%
0.96%
Balyasny Asset Management L.P.
1,068,863US$17.8m27.4%0.05%
0.81%
Federated Hermes, Inc.
907,987US$15.1m-8.97%0.04%
0.78%
Voloridge Investment Management, LLC
870,155US$14.5m-15.4%0.06%
0.77%
Emerald Advisers, LLC
862,209US$14.4m-1.21%0.41%
0.75%
Charles Schwab Investment Management, Inc.
836,214US$13.9m0%no data
0.73%
Palo Alto Investors LP
814,191US$13.6m37.2%2.67%
0.72%
Goldman Sachs Group, Investment Banking and Securities Investments
798,284US$13.3m0%0.01%
0.66%
Millennium Management LLC
735,227US$12.2m171%0.01%
0.66%
Renaissance Technologies LLC
734,354US$12.2m-1.32%0.02%
0.65%
Frontier Capital Management Co LLC
726,324US$12.1m-16.6%0.13%
0.62%
Granite Investment Partners, LLC
686,727US$11.4m0%0.6%
0.56%
C WorldWide Asset Management Fondsmaeglerselskab A/S
621,784US$10.4m0%0.09%
0.55%
Coatue Management, L.L.C.
608,672US$10.1m0%0.04%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/08 12:12
End of Day Share Price 2025/05/07 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

NovoCure Limited is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael KingCitizens JMP Securities, LLC
Gregory GilbertDeutsche Bank
Vijay KumarEvercore ISI